发明名称 |
MTKI QUINAZOLINE DERIVATIVES. |
摘要 |
The present invention concerns the compounds of formula (I) the <i>N</i>-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein Y represents -C<sub>3-9</sub>alkyl-, -C<sub>1-5</sub>alkyl-NR6-C<sub>1-5</sub>alkyl- or -C<sub>1-5</sub>alkyl-NR7-CO-C<sub>1-5</sub>alkyl-; X1 represents -O-; X2 represents NR5-C<sub>1-2</sub>alkyl-; R1 represents hydrogen, halo or Het3-O-; R2 represents hydrogen; R3 represents hydroxy, C<sub>1-4</sub>alkyloxy- or C<sub>1-4</sub>alkyloxy subst ituted with one or two substituents each independently selected from Het4, hydroxy, C<sub>1-4</sub>alkyloxy-, C<sub>1-4</sub>alkyloxy-C<sub>1-4</sub>alkyloxy and NR9R10; R5 represents hydrogen or C<sub>1-4</sub>alkyl; R6 represents hydrogen or C<sub>1-4</sub>alkyl; R7 represents hydrogen; R9 and R10 each independently represent hydrogen; C<sub>1-4</sub>alkyl-S(=O)<sub>2</sub>-C<sub>1-4</sub>alkyl-C(= O)-; C<sub>1-4</sub>alkyl or C<sub>1-4</sub>alkyl substituted with hydroxy; Het3 represents pyridinyl optionally substituted with C<sub>1-4</sub>alkyl; Het4 represents morpholinyl, piperidinyl or piperazinyl wherein said Het4 is optionally substituted with hydroxy-C<sub>1-4</sub>alkyl or C<sub>1-4</sub>alkyl-S(=O)<sub>2</sub>-C<sub>1-4</sub>alkyl-. |
申请公布号 |
MX2009000456(A) |
申请公布日期 |
2009.01.27 |
申请号 |
MX20090000456 |
申请日期 |
2007.07.12 |
申请人 |
JANSSEN PHARMACEUTICA N.V. |
发明人 |
FREYNE, EDDY JEAN EDGARD;WILLEMS, MARC;EMBRECHTS, WERNER CONSTANT JOHAN;TEN HOLTE, PETER;MEVELLEC, LAURENCE ANNE;PAPANIKOS, ALEXANDRA;STORCK, PIERRE-HENRI |
分类号 |
C07D498/14;A61K31/519;A61P35/00 |
主分类号 |
C07D498/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|